Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin For immediate release: December 11, 2023 Boston, MAInfants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H
How IV Drip Therapy in Delhi Works: Step-by-Step IV therapy at The Face Clinic follows a structured, doctor-led clinical process designed to ensure safety, suitability, and individualised care
Carnitene 1 g/10 ml 10 single dose oral solution with L-carnitine supports metabolism of fatty acids, energy and carnitine deficiency in oral vials
The researchers concluded that AOD-9604 represents a promising fat-reducing alternative to growth hormone therapy without its associated metabolic risks, particularly regarding glucose regulation and IGF-1 elevation
hes the reason everyone started slipping a pat of butter into their coffee a few years back
While SUSTAIN-6 and REWIND trials examined GLP-1 RA in diabetics with different cardiovascular risk profile, The Harmony Outcomes study enrolled patients with T2D and established atherosclerotic cardiovascular disease (ASCVD)